Comments*

 
  • Biochemistry, Biophysics & Structural Biology

  • Featured Event

    Green Buildings and Health: From the Lab to the Real World

    Wednesday, December 14, 2016 | 6:00 PM - 8:30 PM
    The New York Academy of Sciences

    Researchers at Harvard T.H. Chan School of Public Health and SUNY Upstate Medical University present the results of a new study showing that employees in high-performing, green-certified buildings had higher cognitive function test scores than those in similarly high-performing buildings that were not green certified, even after controlling for other potential explanatory factors.

  • Events 

    Monday, June 5, 2017 | 12:30 PM - 5:30 PM

    2017 Ross Prize in Molecular Medicine — Regulating Immunity: Fc Receptor Biology

    Featuring: Jeffrey V. Ravetch (The Rockefeller University)

    The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine.

    Tuesday, September 26, 2017 | 9:00 AM - 5:00 PM

    Targeting RNA Using Small Molecules

    Speakers: Nathan J. Baird (National Heart, Lung and Blood Institute, NIH), Matthew D. Disney (Scripps Research Institute), John A. Howe (Merck Research Laboratories), David H. Mathews (University of Rochester), Kevin M. Weeks (University of North Carolina at Chapel Hill), Steven C. Zimmerman (University of Illinois), and John S. Schneekloth, Jr. (National Cancer Institute)

    This symposium will cover approaches for targeting RNA with small and large molecules. The relevance of RNA splicing, microRNA, and RNA repeat expansions to human disease, and novel approaches for selectively modulating RNA function will be discussed.

    Tuesday, November 14, 2017 | 9:00 AM - 5:00 PM

    Antibody–Drug Conjugates: Oncology and Beyond

    Speakers: Philip E. Brandish (Merck & Co), Ryan Fleming (MedImmune), Rakesh K. Jain (Harvard University), Greg Thurber (University of Michigan), Christopher J. O'Donnell (Pfizer), and Laura Saunders (AbbVie)

    This symposium will present cutting-edge research exploring the challenges and opportunities that exist for antibody–drug conjugates as treatments for cancer, and more recently, other disease indications.

  • Past Events

    May 15 - 17, 2017

    13th International Conference on Myasthenia Gravis and Related Disorders

    Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)

    Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.

    February 27 - 28, 2017

    Frontiers in Cancer Immunotherapy

    Keynote Speaker: Padmanee Sharma (The University of Texas MD Anderson Cancer Center)

    Discover the latest on immunotherapeutic strategies that are currently being employed to treat some of the most devastating forms of cancer from leading experts in immunotherapy.
     
    This event is sold out.

    Thursday, January 19, 2017 | 9:00 AM - 5:30 PM

    The New York Structural Biology Discussion Group 12th Winter Meeting

    Organizers: Iban Ubarretxena (Mount Sinai School of Medicine), John Hunt (Columbia University), David Jeruzalmi (City College of New York), Sonya Dougal and Caitlin McOmish (The New York Academy of Sciences)

    The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.
     
    This event is sold out.

    September 21 - 23, 2016

    13th Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms

    Featuring: Peder S. Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.

  • Publications 

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff.

    This special issue presents a collection of four papers ranging from proapoptotic and antiangiogentic properties of resveratrol, to executive function in adults with beta-thalassemia, to disease drivers of aging.

    Volume 1386

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff.

    This diverse collection of papers discusses topics ranging from a paleobiologic study of the emergence of the diaphragm to changes in gait patterns after acute brain injury.

    Annals

    Special Issue: Countermeasures Against Chemical Threats II

    Edited by Jeffrey D. Laskin (Rutgers University School of Public Health)

    Discussions of various countermeasures to chemical threats.

    Annals

    Special Issue: Countermeasures Against Chemical Threats I

    Edited by Jeffrey D. Laskin (Rutgers University School of Public Health)

    Chemical threats, both accidental and deliberate, are of critical concern globally. This, the first of two Annals issues devoted to this topic, presents 23 papers that discuss various countermeasures against chemical threats.

    Volume 1374